These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9558061)

  • 1. Predictable TCR antigen recognition based on peptide scans leads to the identification of agonist ligands with no sequence homology.
    Hemmer B; Vergelli M; Gran B; Ling N; Conlon P; Pinilla C; Houghten R; McFarland HF; Martin R
    J Immunol; 1998 Apr; 160(8):3631-6. PubMed ID: 9558061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantigen recognition by human CD8 T cell clones: enhanced agonist response induced by altered peptide ligands.
    Dressel A; Chin JL; Sette A; Gausling R; Höllsberg P; Hafler DA
    J Immunol; 1997 Nov; 159(10):4943-51. PubMed ID: 9366420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A molecular basis for how a single TCR interfaces multiple ligands.
    Boesteanu A; Brehm M; Mylin LM; Christianson GJ; Tevethia SS; Roopenian DC; Joyce S
    J Immunol; 1998 Nov; 161(9):4719-27. PubMed ID: 9794402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis of specificity and degeneracy of T cell recognition: pluriallelic restriction of T cell responses to a peptide antigen involves both specific and promiscuous interactions between the T cell receptor, peptide, and HLA-DR.
    Doherty DG; Penzotti JE; Koelle DM; Kwok WW; Lybrand TP; Masewicz S; Nepom GT
    J Immunol; 1998 Oct; 161(7):3527-35. PubMed ID: 9759873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possibilities and limitations in the rational design of modified peptides for T cell mediated immunotherapy.
    de Haan EC; Moret EE; Wagenaar-Hilbers JP; Liskamp RM; Wauben MH
    Mol Immunol; 2005 Feb; 42(3):365-73. PubMed ID: 15589325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential activation of human autoreactive T cell clones by altered peptide ligands derived from myelin basic protein peptide (87-99).
    Vergelli M; Hemmer B; Utz U; Vogt A; Kalbus M; Tranquill L; Conlon P; Ling N; Steinman L; McFarland HF; Martin R
    Eur J Immunol; 1996 Nov; 26(11):2624-34. PubMed ID: 8921948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural basis of molecular mimicry.
    Wucherpfennig KW
    J Autoimmun; 2001 May; 16(3):293-302. PubMed ID: 11334495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Limited plasticity in T cell recognition of modified T cell receptor contact residues in MHC class II bound peptides.
    de Haan EC; Wagenaar-Hilbers JP; Liskamp RM; Moret EE; Wauben MH
    Mol Immunol; 2005 Feb; 42(3):355-64. PubMed ID: 15589324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T cell receptor crossreactivity as a general property of T cell recognition.
    Wucherpfennig KW
    Mol Immunol; 2004 Feb; 40(14-15):1009-17. PubMed ID: 15036904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in TCR-MHC contacts subsequent to cross-recognition of class I MHC and singly substituted peptide variants.
    Ono T; DiLorenzo TP; Wang F; Kalergis AM; Nathenson SG
    J Immunol; 1998 Nov; 161(10):5454-63. PubMed ID: 9820521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural features of autoreactive TCR that determine the degree of degeneracy in peptide recognition.
    Hausmann S; Martin M; Gauthier L; Wucherpfennig KW
    J Immunol; 1999 Jan; 162(1):338-44. PubMed ID: 9886404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity. I. Use of peptide libraries to identify epitopes that activate clonotypic CD4+ T cells and induce T cell responses to native peptide ligands.
    Wilson DB; Pinilla C; Wilson DH; Schroder K; Boggiano C; Judkowski V; Kaye J; Hemmer B; Martin R; Houghten RA
    J Immunol; 1999 Dec; 163(12):6424-34. PubMed ID: 10586032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantigen-responsive T cell clones demonstrate unfocused TCR cross-reactivity toward multiple related ligands: implications for autoimmunity.
    Anderson AC; Waldner H; Turchin V; Jabs C; Prabhu Das M; Kuchroo VK; Nicholson LB
    Cell Immunol; 2000 Jun; 202(2):88-96. PubMed ID: 10896768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered peptide ligands of islet autoantigen Imogen 38 inhibit antigen specific T cell reactivity in human type-1 diabetes.
    Geluk A; van Meijgaarden KE; Roep BO; Ottenhoff TH
    J Autoimmun; 1998 Aug; 11(4):353-61. PubMed ID: 9776713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In the normal repertoire of CD4+ T cells, a single class II MHC/peptide complex positively selects TCRs with various antigen specificities.
    Chmielowski B; Muranski P; Ignatowicz L
    J Immunol; 1999 Jan; 162(1):95-105. PubMed ID: 9886374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Degenerate recognition of a dissimilar antigenic peptide by myelin basic protein-reactive T cells. Implications for thymic education and autoimmunity.
    Bhardwaj V; Kumar V; Geysen HM; Sercarz EE
    J Immunol; 1993 Nov; 151(9):5000-10. PubMed ID: 7691962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modification of peptide interaction with MHC creates TCR partial agonists.
    Ryan KR; McNeil LK; Dao C; Jensen PE; Evavold BD
    Cell Immunol; 2004 Jan; 227(1):70-8. PubMed ID: 15051516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide recognition by two HLA-A2/Tax11-19-specific T cell clones in relationship to their MHC/peptide/TCR crystal structures.
    Hausmann S; Biddison WE; Smith KJ; Ding YH; Garboczi DN; Utz U; Wiley DC; Wucherpfennig KW
    J Immunol; 1999 May; 162(9):5389-97. PubMed ID: 10228016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serial TCR engagement and down-modulation by peptide:MHC molecule ligands: relationship to the quality of individual TCR signaling events.
    Itoh Y; Hemmer B; Martin R; Germain RN
    J Immunol; 1999 Feb; 162(4):2073-80. PubMed ID: 9973480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modifications of peptide ligands enhancing T cell responsiveness imply large numbers of stimulatory ligands for autoreactive T cells.
    Vergelli M; Hemmer B; Kalbus M; Vogt AB; Ling N; Conlon P; Coligan JE; McFarland H; Martin R
    J Immunol; 1997 Apr; 158(8):3746-52. PubMed ID: 9103439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.